BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2001
View Archived Issues
Genzyme General reports Q1 2001 update
Read More
High exposure to ISIS-2302 associated with significant clinical response in Crohn's disease
Read More
Efficacy and safety results from phase II BXT-51072 trial discussed at DDW
Read More
Endovasc's Liprostin bypasses phase I/II and enters phase III for critical limb ischemia
Read More
Statistically significant reductions in BP reported for enalapril/nitrendipine
Read More
U.S. Army to test CT-3 in vivo
Read More
DDW news: selective adenosine A2A activation as a novel approach to IBD
Read More
Reversal of cardiomyopathy demonstrated in phase II trial of Replagal
Read More
High two-year survival rates obtained in stage III melanoma patients immunized with TriGem
Read More
OP-1 Implant receives second major approval
Read More
Replication-competent virus for i.v. administration tested in cancer patients
Read More
Company Profile: BioAxone Therapeutic
Read More
Yasmin receives FDA approval
Read More
Nabi begins trial to evaluate booster dose of Nabi StaphVAX in immunocompromised patients
Read More
GTI-2040 safe and well tolerated in initial dose-escalating trial
Read More
FDA approves clinical testing of ErythroMax cell-based oxygen therapeutic
Read More
ASCO presentation documents safety of TLK-286 over wide dose range, efficacy in advanced cancer
Read More
Effexor gains new FDA labeling approval regarding relapse
Read More
Abarelix as a new hormonal therapy for safely inducing medical castration in prostate cancer
Read More
Tachykinin antagonist/GABA analogue combinations useful for psychiatric disorders
Read More
Merck presents amine derivatives with PDE5-inhibitory effects
Read More
Subtype-selective NMDA receptor blockers and uses disclosed by Roche
Read More
Novel inhibitors of alphav integrin receptors discovered by Amgen team
Read More
Imidazole-based cytokine inhibitors designed at Merck & Co.
Read More
Novel treatments for CNS disorders emerge from R&D at Fujisawa
Read More
Pharmaceutically active compounds from Applied Research target JNK pathway
Read More
Boston Life Sciences' O-1369 shows promise in primates with Parkinson's disease
Read More
InterMune and MoliChem initiate pulmonary disease collaboration
Read More